Self-Assembled Nanoconstructs Modified with Amplified Aptamers Inhibited Tumor Growth and Retinal Vascular Hyperpermeability via Vascular Endothelial Growth Factor Capturing
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jihyun Lee | - |
dc.contributor.author | Lee B.J. | - |
dc.contributor.author | Yeong Mi Lee | - |
dc.contributor.author | Park H. | - |
dc.contributor.author | Kim J.H. | - |
dc.contributor.author | Won Jong Kim | - |
dc.date.available | 2017-06-28T07:46:47Z | - |
dc.date.created | 2017-05-19 | - |
dc.date.issued | 2017-05 | - |
dc.identifier.issn | 1543-8384 | - |
dc.identifier.uri | https://pr.ibs.re.kr/handle/8788114/3628 | - |
dc.description.abstract | Here, nanoconstructs consisting of a DNA-amplified aptamer with a biocompatible polymer backbone for capturing target biomolecules are presented. First, the polymer-DNA nanoconstructs were prepared by hybridization of two complementary single-stranded DNAs that were each conjugated to a dextran polymer backbone. The designed polymer-DNA amplified aptamer nanoconstructs (PA-aNCs) were then prepared by utilizing polymer-DNA nanoconstructs conjugated with an aptamer (PA-NCs) using a rolling circle amplification reaction to amplify the aptamer. These PA-aNCs were successfully applied to alleviate tumor growth and vascular endothelial growth factor (VEGF)-induced retinal vascular hyperpermeability in vivo through the highly effective capture of human VEGF as a target molecule. These PA-aNCs could be used as therapeutic agent for anti-VEGF therapy by efficiently capturing human VEGF. © 2017 American Chemical Society | - |
dc.description.uri | 1 | - |
dc.language | 영어 | - |
dc.publisher | AMER CHEMICAL SOC | - |
dc.subject | anti-VEGF therapy | - |
dc.subject | antitumor therapy | - |
dc.subject | DNA nanoconstructs | - |
dc.subject | polymer−DNA conjugates | - |
dc.subject | retinal vascular hyperpermeability | - |
dc.title | Self-Assembled Nanoconstructs Modified with Amplified Aptamers Inhibited Tumor Growth and Retinal Vascular Hyperpermeability via Vascular Endothelial Growth Factor Capturing | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.identifier.wosid | 000400633300014 | - |
dc.identifier.scopusid | 2-s2.0-85018397688 | - |
dc.identifier.rimsid | 59478 | ko |
dc.date.tcdate | 2018-10-01 | - |
dc.contributor.affiliatedAuthor | Jihyun Lee | - |
dc.contributor.affiliatedAuthor | Yeong Mi Lee | - |
dc.contributor.affiliatedAuthor | Won Jong Kim | - |
dc.identifier.doi | 10.1021/acs.molpharmaceut.6b00949 | - |
dc.identifier.bibliographicCitation | MOLECULAR PHARMACEUTICS, v.14, no.5, pp.1460 - 1468 | - |
dc.citation.title | MOLECULAR PHARMACEUTICS | - |
dc.citation.volume | 14 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 1460 | - |
dc.citation.endPage | 1468 | - |
dc.date.scptcdate | 2018-10-01 | - |
dc.description.wostc | 2 | - |
dc.description.scptc | 2 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordAuthor | anti-VEGF therapy | - |
dc.subject.keywordAuthor | antitumor therapy | - |
dc.subject.keywordAuthor | DNA nanoconstructs | - |
dc.subject.keywordAuthor | polymer−DNA conjugates | - |
dc.subject.keywordAuthor | retinal vascular hyperpermeability | - |